```html

Quasi‑hereditary Bruising

What is Quasi‑hereditary bruising?

Quasi‑hereditary bruising is a term used to describe a tendency to develop bruises (ecchymoses) that appears to run in families but does not follow a classic Mendelian inheritance pattern. In other words, the bruising‑prone trait shows up more often among relatives than would be expected by chance, yet the underlying genetic cause is usually complex, involving multiple genes and environmental factors.

People with quasi‑hereditary bruising may notice that minor bumps or even normal daily activities leave dark, often painful spots on the skin that last longer than typical bruises. The condition is not a disease by itself; it is a clinical observation that can be a clue to an underlying bleeding or connective‑tissue disorder, or occasionally a benign familial trait.

Understanding the difference between “normal” bruising (which can happen to anyone) and quasi‑hereditary bruising is important because it can lead to early detection of serious hematologic or vascular disorders.

Common Causes

Quasi‑hereditary bruising is most often a manifestation of another condition. Below are the most frequently reported causes, ordered from genetic‑predisposing disorders to acquired states.

• Von von Gieson syndrome (Hereditary hemorrhagic telangiectasia, HHT) – Autosomal‑dominant vascular malformations that weaken vessel walls.
• Ehlers‑Danlos syndrome, especially the vascular type (vEDS) – Defects in collagen synthesis make skin and vessels fragile.
• Platelet function disorders (e.g., Bernard‑Soulier syndrome, Glanzmann thrombasthenia).
• Coagulation factor deficiencies such as mild hemophilia A/B or factor XIII deficiency.
• Vitamin C deficiency (scurvy) – Impairs collagen cross‑linking, leading to fragile capillaries.
• Vitamin K deficiency or antagonism (e.g., warfarin use, malabsorption).
• Systemic lupus erythematosus (SLE) and other autoimmune vasculitides – Immune‑mediated damage to small vessels.
• Thyroid disorders – Both hyper‑ and hypothyroidism can affect platelet function.
• Chronic liver disease – Reduces synthesis of clotting factors and thrombopoietin.
• Medication‑induced bruising – Steroids, anticoagulants, antiplatelet agents, and certain antibiotics (e.g., fluoroquinolones).

Associated Symptoms

Depending on the underlying cause, bruising may be accompanied by other clinical clues:

• Frequent nosebleeds or gum bleeding.
• Joint swelling or hemarthrosis (especially in hemophilia).
• Skin hyper‑elasticity, hypermobile joints, or easy skin tearing (suggesting Ehlers‑Danlos).
• Recurrent headaches, visual changes, or neurological deficits (possible intracranial hemorrhage).
• Fatigue, easy bruising on the torso, and gastrointestinal bleeding (liver disease).
• Oral ulcers, photosensitivity, or a “butterfly” facial rash (SLE).
• Shortness of breath, chest pain, or palpitations (possible pulmonary AVMs in HHT).
• Bleeding after minor dental procedures or surgery.

When to See a Doctor

Most bruises are harmless, but you should seek medical evaluation when any of the following apply:

• Bruises appear without known trauma, especially on the torso, face, or inside the mouth.
• Bruising is unusually large (>4 cm), painful, or does not fade after 2–3 weeks.
• You have a personal or family history of bleeding disorders.
• Bruising is accompanied by frequent nosebleeds, heavy menstrual bleeding, or prolonged bleeding after cuts.
• Unexplained fatigue, anemia, or weight loss develop alongside bruising.
• Any signs of internal bleeding (e.g., black/tarry stools, bright red blood in urine, coughing up blood).
• You are taking blood‑thinners or antiplatelet drugs and notice a sudden increase in bruising.

Diagnosis

Evaluation is stepwise and aims to uncover an underlying systemic cause.

1. Detailed Medical History

• Onset, frequency, and location of bruises.
• Family history of bleeding, easy bruising, or connective‑tissue disorders.
• Medication and supplement review (including over‑the‑counter NSAIDs).
• Associated symptoms such as joint pain, rashes, or gastrointestinal bleeding.

2. Physical Examination

• Inspection of skin for pattern of bruises, telangiectasias, or hyper‑elasticity.
• Joint mobility assessment (Ehlers‑Danlos screening).
• Oral and nasal cavity examination for mucosal bleeding.
• Abdominal and cardiovascular exam for organomegaly or heart murmurs.

3. Laboratory Tests

• Complete blood count (CBC) – looks for anemia or platelet count abnormalities.
• Prothrombin time (PT) and International Normalized Ratio (INR) – evaluates the extrinsic clotting pathway.
• Activated partial thromboplastin time (aPTT) – assesses the intrinsic pathway.
• Platelet function analysis (e.g., PFA‑100, aggregometry) if platelet disorder is suspected.
• Serum levels of vitamin C, vitamin K, and folate.
• Liver function tests and serum albumin – screen for chronic liver disease.
• Specific factor assays (VIII, IX, XIII) if hemophilia is considered.
• Autoimmune panel (ANA, anti‑dsDNA, complement levels) for SLE.

4. Imaging (when indicated)

• Ultrasound or CT scan to rule out internal hematomas.
• MRI of the brain if neurological symptoms are present.
• Contrast‑enhanced CT or MR angiography for suspected AVMs in HHT.

5. Genetic Testing

Targeted panels or whole‑exome sequencing can identify pathogenic variants in COL3A1 (vEDS), ENG/ACVRL1 (HHT), or other bleeding‑disorder genes. Testing is usually reserved for patients with a compelling family history or confirmed clinical suspicion.

Treatment Options

Treatment focuses on the underlying cause, symptom control, and minimizing future bruising.

1. General Measures

• Gentle skin care: avoid tight clothing, abrasive soaps, and vigorous rubbing.
• Cold compresses (within the first 24 h) to reduce capillary leakage.
• Elevate bruised limbs to decrease swelling.
• Balanced diet rich in vitamins C and K, protein, and iron.

2. Pharmacologic Management

• Vitamin supplementation – oral vitamin C (500‑1000 mg/day) for scurvy, vitamin K2 (90‑200 µg/day) if deficiency is documented.
• Desmopressin (DDAVP) – short‑term boost of factor VIII and von Willebrand factor for mild hemophilia or platelet dysfunction.
• Tranexamic acid – antifibrinolytic useful for mucosal bleeding and post‑procedural prophylaxis.
• Hormonal therapy – combined oral contraceptives can lessen heavy menstrual bleeding in some women.
• Immunosuppressants – low‑dose prednisone or hydroxychloroquine for SLE‑related bruising.
• Targeted therapy for HHT – bevacizumab (anti‑VEGF) or thalidomide in refractory cases.

3. Surgical / Procedural Interventions

• Embolization of high‑flow AVMs.
• Liver transplantation in end‑stage cirrhosis with severe coagulopathy.
• Repair of tendon or ligament ruptures that may occur secondary to fragile connective tissue.

4. Lifestyle Adjustments

• Use soft‑bristled toothbrushes and electric razors to reduce skin trauma.
• Avoid high‑impact sports or activities that carry a high risk of blows to the torso or head.
• Stay hydrated; dehydration can thicken blood and increase vascular fragility.

Prevention Tips

• Maintain a diet adequate in vitamins C, K, and B12 and minerals such as zinc and iron.
• Review medication list with a pharmacist; ask if any drug could increase bruising risk.
• Wear protective gear (helmets, padded clothing) during activities that could cause blunt trauma.
• Apply sunscreen and protect skin from chronic sun damage, which can weaken superficial vessels.
• Schedule regular health check‑ups if you have a known family history of bleeding or connective‑tissue disorders.
• Practice good oral hygiene with a soft toothbrush to prevent gum bleeding.
• Manage chronic conditions (e.g., liver disease, thyroid disorders) under the guidance of a specialist.

Emergency Warning Signs

If any of the following develop, seek immediate medical attention (call emergency services or go to the nearest emergency department):

• Rapidly spreading bruising or a bruise larger than 5 cm without a clear injury.
• Severe abdominal pain accompanied by a new bruise on the abdomen – possible internal bleeding.
• Sudden headache, vision changes, or loss of consciousness – could indicate intracranial hemorrhage.
• Chest pain, shortness of breath, or coughing up blood.
• Vomiting blood or passing black, tarry stools (melena).
• Unexplained swelling and pain in a joint, especially if you have a known clotting disorder.
• Bleeding that does not stop after applying firm pressure for 10‑15 minutes.

---

Sources: Mayo Clinic, National Institutes of Health (NIH) – MedlinePlus, Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), Cleveland Clinic, and peer‑reviewed journals (Blood, The Journal of Thrombosis and Haemostasis).

```